![Björn Löwenadler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Björn Löwenadler
Corporate Officer/Principal presso TOLERANZIA AB
Provenienza dei contatti di primo grado di Björn Löwenadler
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Björn Löwenadler tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Pierre Fabre SA
![]() Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
RECIPHARM AB (PUBL) | Biotechnology | Founder | |
Arexis AB
![]() Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
University of Leiden | College/University | Doctorate Degree | |
Recipharm Monts SAS
![]() Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Monts SAS is a company that manufactures sterile injectable anesthetic products. The company is based in Monts, France. Carl Ericson has been the CEO of the French company since 2019. | Pharmaceuticals: Major | Chairman | |
University of Gothenburg | College/University | Doctorate Degree Undergraduate Degree | |
KAHR Medical Ltd.
![]() KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
SymCel AB
![]() SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member | |
Aesica Formulation Development Ltd.
![]() Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Handelshögskolan i Göteborg | College/University | Graduate Degree | |
Novartis Sverige AB
![]() Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca R&D Mölndal | Corporate Officer/Principal Corporate Officer/Principal | ||
VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Director/Board Member | |
Culture Group Ltd. | Director/Board Member | ||
Aesica Holdco Ltd.
![]() Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The company is based in Hemel Hempstead, UK. | Pharmaceuticals: Major | Director/Board Member | |
MetaboGen AB
![]() MetaboGen AB Internet Software/ServicesTechnology Services MetaboGen AB operates a metagenome and metabolic disease platform. It provides commercial access to metagenome research and development. The firm offers create next generation probiotics and pharmaceutical products, based on the microbiome. The company was founded in 2011 and is headquartered in Göteborg, Sweden. | Internet Software/Services | Director/Board Member | |
Kulturtuben AB | Director/Board Member | ||
XINTELA AB | Biotechnology | Director/Board Member | |
Recipharm Fontaine SAS
![]() Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Fontaine SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Fontaine-les-Dijon, France. The company was founded in 2008. Pascal Prudent has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman | |
Oncorena Holding AB
![]() Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Bohus HoldCo AB
![]() Bohus HoldCo AB Chemicals: Major DiversifiedProcess Industries Bohus BioTech AB is a Swedish company that manufactures and develops hyaluronic acid products. The company is based in Stromstad, Sweden and has subsidiaries in Sweden. The company was founded in 1992 by Daniel C. Ogbonnaya. | Chemicals: Major Diversified | Director/Board Member | |
Flerie Participation AB
![]() Flerie Participation AB Financial ConglomeratesFinance Flerie Participation AB is an investment holding Swedish company. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
INTEGRUM AB | Medical Specialties | Director of Finance/CFO | |
STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Prokarium Ltd.
![]() Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Fullriggaren Konsult AB | Director of Finance/CFO | ||
Gypius AB
![]() Gypius AB Media ConglomeratesConsumer Services Gypius AB provides support services for artistic activities. The private company is based in Gothenburg, Sweden. | Media Conglomerates | Director/Board Member | |
Amarna Therapeutics BV
![]() Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Chairman | |
C. D. S. GmbH
![]() C. D. S. GmbH RestaurantsConsumer Services C. D. S. GmbH provides catering services. The private company is based in Reichertshofen, Germany. The CEO of the German company is Lorenz Weichselbaumer. | Restaurants | Director/Board Member | |
Recipharm Verwaltungs GmbH
![]() Recipharm Verwaltungs GmbH Financial ConglomeratesFinance Part of Recipharm AB, Recipharm Verwaltungs GmbH is an investment holding German company. The company is based in Wasserburg am Inn, Germany. The CEOs of the company are Michael Isele, Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
Prokarium Holdings Ltd.
![]() Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman | |
Recipharm Holdings Ltd.
![]() Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. | Miscellaneous | Director/Board Member | |
Lorensbergsteatern | Director/Board Member | ||
Consort Medical GmbH
![]() Consort Medical GmbH Financial ConglomeratesFinance Part of Recipharm AB, Consort Medical GmbH is a German company that functions as an investment holding company. The company is based in Monheim, Germany. The CEO of the company is Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
CIRCHEM AB | Chemicals: Major Diversified | Director of Finance/CFO | |
VWH & Co. AB | Director/Board Member | ||
Castello Di Vaglio Serra AB | Director/Board Member | ||
Sobrera Pharma AB
![]() Sobrera Pharma AB Pharmaceuticals: MajorHealth Technology Sobrera Pharma AB manufactures pharmaceutical products for patients with alcohol use disorders. The company is based in Gothenburg, Sweden. The CEO of the Swedish company is Ann-Charlotte Rosendahl. | Pharmaceuticals: Major | Chief Executive Officer | |
Buzzard Pharmaceuticals AB
![]() Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member | |
Kulturlådan AB | Director/Board Member | ||
Kulturpåsen AB | Director/Board Member | ||
Rolfallan Design AB | Director/Board Member | ||
Besattningen 1 Kommanditbolag | Corporate Officer/Principal | ||
NorthX Biologics Matfors AB
![]() NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Biotechnology | Chairman | |
NANOLOGICA AB | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Svezia | 34 |
Regno Unito | 7 |
Francia | 6 |
Germania | 4 |
Paesi Bassi | 3 |
Settori
Health Technology | 24 |
Consumer Services | 7 |
Finance | 4 |
Process Industries | 3 |
Commercial Services | 3 |
Posizioni
Director/Board Member | 48 |
Chairman | 13 |
Corporate Officer/Principal | 11 |
Chief Executive Officer | 7 |
Founder | 7 |
Contatti più connessi
- Borsa valori
- Insiders
- Björn Löwenadler
- Connessioni Società